-
Chemed (CHE) PT Raised to $667 at RBC Capital, Citing 'Continued VITAS Momentum'
-
Chemed (CHE) PT Lowered to $633 at RBC Capital
-
Chemed (CHE) PT Lowered to $697 at RBC Capital
-
Chemed Corporation to Present at the 2023 RBC Global Healthcare Conference
-
Chemed Corporation to Present at the 2022 RBC Capital Markets Global Healthcare Conference
-
Chemed Corporation to Present at the 2021 RBC Capital Markets Global Healthcare Conference
-
RBC Capital Upgrades Chemed (CHE) to Outperform
-
Chemed (CHE) PT Raised to $410 at RBC Capital
-
Chemed (CHE) PT Raised to $405 at RBC Capital
-
Chemed Corporation to Present at the 2019 RBC Capital Markets Global Healthcare Conference
-
Chemed (CHE) PT Raised to $318 at RBC Capital
-
Chemed (CHE) PT Lowered to $313 at RBC Capital
-
Chemed (CHE) PT Raised to $321 at RBC Capital
-
Chemed (CHE) PT Raised to $296 at RBC Capital
-
Chemed Corporation to Present at the 2018 RBC Capital Markets’ Global Healthcare Conference
-
Chemed Corporation to Present at the 2017 RBC Capital Markets’ Global Healthcare Conference
-
Chemed Corporation to Present at the 2016 RBC Capital Markets’ Global Healthcare Conference
-
Notable Analyst Rating Changes 02/17: SNDK, HD, WFMI, ABFS Upgraded; VCLK, SNI, PAAS, CHE Downgraded
-
RBC Capital Downgrades Chemed (CHE) to Sector Perform
-
RBC Capital Initiates Coverage on Several Healthcare Stocks

